These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3776104)

  • 21. Synthesis of tetrasubstituted bicyclo[3.2.1]octenes as potential inhibitors of influenza virus sialidase.
    Jones PS; Smith PW; Hardy GW; Howes PD; Upton RJ; Bethell RC
    Bioorg Med Chem Lett; 1999 Feb; 9(4):605-10. PubMed ID: 10098673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site.
    Finley JB; Atigadda VR; Duarte F; Zhao JJ; Brouillette WJ; Air GM; Luo M
    J Mol Biol; 1999 Nov; 293(5):1107-19. PubMed ID: 10547289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in splitting capacity of virus and V. cholerae neuraminidases on sialic acid type substrates.
    Drzeniek R
    Biochem Biophys Res Commun; 1967 Mar; 26(6):631-8. PubMed ID: 6030973
    [No Abstract]   [Full Text] [Related]  

  • 24. Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: modifications of essential pyrrolidinone ring substituents.
    Brouillette WJ; Bajpai SN; Ali SM; Velu SE; Atigadda VR; Lommer BS; Finley JB; Luo M; Air GM
    Bioorg Med Chem; 2003 Jul; 11(13):2739-49. PubMed ID: 12788348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of a tetrasubstituted bicyclo [2.2.2] octane as a potential inhibitor of influenza virus sialidase.
    Smith PW; Trivedi N; Howes PD; Sollis SL; Rahim G; Bethell RC; Lynn S
    Bioorg Med Chem Lett; 1999 Feb; 9(4):611-4. PubMed ID: 10098674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of 1,4,5,6-tetrahydropyridazine derivatives as influenza neuraminidase inhibitors.
    Zhang L; Williams MA; Mendel DB; Escarpe PA; Chen X; Wang KY; Graves BJ; Lawton G; Kim CU
    Bioorg Med Chem Lett; 1999 Jul; 9(13):1751-6. PubMed ID: 10406636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The N2 neuraminidase of human influenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity.
    Baum LG; Paulson JC
    Virology; 1991 Jan; 180(1):10-5. PubMed ID: 1984642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baloxavir marboxil (Xofluza) for treatment of influenza.
    Med Lett Drugs Ther; 2018 Dec; 60(1561):193-196. PubMed ID: 30653474
    [No Abstract]   [Full Text] [Related]  

  • 29. [Analysis of the antigenic specificity of the neuraminidases of influenza B viruses isolated in different years].
    Liubovtseva OV; Brydak L; Oskerko TA; Iakhno MA; Zakstel'skaia LIa
    Vopr Virusol; 1987; 32(3):285-9. PubMed ID: 2445105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sensitivity of the epidemic and pandemic influenza virus strains to zanamivir (Relenze) in in vitro experiments].
    L'vov DK; Burtseva EI; Galegov GA; Beliakova NV; Shevchenko ES; Kolobukhina LV; Merkulova LN; Prilipov AG; Leneva IA; Baranov NI; Gorelikov VN; Abramov DD
    Vopr Virusol; 2010; 55(6):10-4. PubMed ID: 21381333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuraminidase mutations conferring resistance to laninamivir lead to faster drug binding and dissociation.
    McKimm-Breschkin JL; Barrett S
    Antiviral Res; 2015 Feb; 114():62-6. PubMed ID: 25499124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Difficulties in standardizing the neuraminidase content of influenza vaccines.
    Gérentes L; Kessler N; Aymard M
    Dev Biol Stand; 1999; 98():189-96; discussion 197. PubMed ID: 10494973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A novel test for diagnosis of influenza].
    Guo Y; Wen L; Wang M; Zhang Y; Guo J; Li Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):207-10. PubMed ID: 12665920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors.
    Kim CU; Lew W; Williams MA; Wu H; Zhang L; Chen X; Escarpe PA; Mendel DB; Laver WG; Stevens RC
    J Med Chem; 1998 Jul; 41(14):2451-60. PubMed ID: 9651151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystallization and preliminary X-ray analyses of two neuraminidases from influenza B virus strains B/Hong Kong/8/73 and B/Lee/40.
    Bossart PJ; Babu YS; Cook WJ; Air GM; Laver WG
    J Biol Chem; 1988 May; 263(13):6421-3. PubMed ID: 3360786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbocyclic influenza neuraminidase inhibitors possessing a C3-cyclic amine side chain: synthesis and inhibitory activity.
    Lew W; Wu H; Chen X; Graves BJ; Escarpe PA; MacArthur HL; Mendel DB; Kim CU
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1257-60. PubMed ID: 10866394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase.
    Crennell SJ; Garman EF; Laver WG; Vimr ER; Taylor GL
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9852-6. PubMed ID: 8234325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors.
    Boivin G; Goyette N
    Antiviral Res; 2002 Jun; 54(3):143-7. PubMed ID: 12062387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1,2,3-Triazolyl-4-oxoquinolines: A feasible beginning for promising chemical structures to inhibit oseltamivir-resistant influenza A and B viruses.
    Boechat Fda C; Sacramento CQ; Cunha AC; Sagrillo FS; Nogueira CM; Fintelman-Rodrigues N; Santos-Filho O; Riscado CS; Forezi Lda S; Faro LV; Brozeguini L; Marques IP; Ferreira VF; Souza TM; de Souza MC
    Bioorg Med Chem; 2015 Dec; 23(24):7777-84. PubMed ID: 26643220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay.
    Eichelberger MC; Hassantoufighi A; Wu M; Li M
    Virol J; 2008 Sep; 5():109. PubMed ID: 18822145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.